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Three-dimensional human skin wound infection equivalent as a tool for 
bioanalysis of antimicrobial polymeric biomaterials for wound dressings
Introduction: The aim of this study was the development of a human skin wound infection
model for the bio-evaluation of antimicrobial biomaterials intended for wound healing purposes.
Development of human-based three-dimensional in vitro systems with bacterial infection and
biofilm formation will serve as an advanced and complex system to perform more reliable preclinical
studies. These systems will be employed for in vitro screening of both antibacterial activity as well as
cytocompatibility of the studied material to obtain better in vivo performances.
Methods: The 3D skin equivalent was obtained having both a dermal and an epidermal
compartment, by embedding human primary fibroblasts in rat tail tendon collagen type I hydrogel
(mimicking skin extracellular matrix) and then seeding human primary keratinocytes on it to
generate the epidermal layer. The model was characterized for morphological characteristics and
dermal/epidermal markers through histological and immunohistochemical analysis, respectively. To
assess the viability of the system quantitatively, different cell viability and cytotoxicity assays e.g.
CellTiter-Blue, CytoTox-ONE, RealTime-Glo MT, CellTiter-Glo (Promega) were evaluated to
finally optimize the best suited assay to the respective cell types and eventually to the 3D system.
This model would be inoculated with clinically challenging bacteria e.g. Staphylococcus aureus to
generate a 3D wound infection model.
0
10000
20000
30000
40000
50000
60000
Day 5 Day 7 Day 10 Day 12 Day 14 Day 16 Day 18 Day 20
Fl
u
o
re
sc
e
n
ce
 5
6
0
/5
9
0
n
m
 (
R
FU
)
Cell Viability
CytoToxicity
Quantitative measurement of cell viability of 3D 
fibroblasts (in a preliminary dermal model)
Fig 4: A dermal model based on L929 fibroblasts was used for optimization
of cytocompatibility measurement as a quantitative analysis of viable and
dead cells overtime. The results showed that cells stayed viable inside the
matrix for at least 20 days that is a pre-requirement of the in vitro model.
Both assays (CellTiter-Blue and CytoTox-ONE) were adapted and
optimized to this 3D dermal system. Repeated exposure of cells to reagent
(results not shown here) up to 18 days had no lasting toxic effect.
Therefore, this assay is suitable as a method to monitor cell viability of the
same sample over an extended time frame.
Fig 8: The graphs show the results of viability of human primary
fibroblasts in 3D dermal model. Therefore, after selecting CellTiter-
Glo as an appropriate assay, cell viability in the 3D dermal model
(based on primary dermal fibroblasts) was measured over time
and the results showed that cells not only stayed viable inside the
matrix but were also proliferating over time.
Protocol was improved for this assay in 3D system by optimizing
the shaking time. Results showed that increased shaking time
resulted in higher cell lytic capacity for maximum ATP release. 30
minutes shaking time for a “7 days cultured dermal model” gave
2.4 times higher value than the one at lower shaking time of 5
min.
However, shaking times varied for the measurement of cell
viability of 3D system at different time points, indicating the
matrix-cell interaction and thus, density variation with increasing
culture time.
Optimization of cell viability measurement of human fibroblasts
Development of 3D skin model
Visualization of dermal fibroblasts in 3D
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Fig 1: The model was established
by first optimizing the dermal
part of skin. The Z-stacked
imaging revealed the filopodia
like morphology and a uniform
distribution of human fibroblasts
at different planes inside the
matrix. The dermal layer showed
fibroblasts with dendritic
extensions in the matrix.
However, no morphological
differences were found among
different collagen I matrix
concentrations. Fluorescent
microscopic images show cell
nuclei stained with DAPI and F-
actin of cells stained with
Phalloidin. Scale bar=100 µm
Fig 2: Hematoxylin/Eosin (H & E) stained histological images of in vitro
human skin model after 10 days at Air Liquid Interface (ALI) (a), 15 days
at ALI (b), 20 days at ALI (c). The results showed the two structurally
distinct layers of skin: the outer epidermis layer and the underlying
thicker dermis layer that consists of connective tissue. The epidermal
part showed well differentiated layers of keratinocytes namely stratum
corneum, granulosum, spinosum and basale, well-organized after 20
days at ALI. Furthermore, the contact between dermal and epidermal
surface was not straight rather it was undulating in a way that it
intertwined with dermal layer; mimicking the in vivo situation. Scale bar=
100 and 200 µm
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Fig 7: CellTiter-Glo
Fig 5: The results showed that CellTiter-Blue assay was able to
measure cell viability of primary cells (human fibroblasts and
keratinocytes). However, microscopic observations (Fig 6a,b)
showed that reagent affected cell morphology of human fibroblasts
(unlike L929 fibroblast) indicating reagent interference with cell
normal biological activity, resulting in less reliable data. Therefore,
this assay would not provide definitive results in a clinically relevant
model based on human primary cells (that is more sensitive than a
model based on cell lines). Scale bar=100 µm
Fig 9: Testing of antibacterial biomaterials 
intended for wound healing purposes
Antibacterial biomaterial
Biomaterial 
(to be tested)
Bacteria
Fig 6b
Control: No reagent exposure to
human primary fibroblasts.
Fig 6a
CellTiter reagent exposure to
human primary fibroblasts.
Development and optimization of quantitative 
cytocompatibility assays for in vitro human skin model
Fig 7: CellTiter-Glo was found to be
the optimal cell viability assay among
those analyzed. For example, CellTiter-
Blue affected cell morphology and
RealTime-Glo did not provide a
linear signal with even as low as 2500
cell number (data not shown), which
made these assays unsuitable for the
system.
Results showed that the CellTiter-Glo
assay was able to measure as high as
100,000 cells.
Parameters were optimized for this
assay (data not shown). For example,
results showed that half life of signal
measured was more than 4 hours.
Fig 9: Future perspective:
Staphylococcus aureus, a major
bacterial pathogen would be allowed
to grow in this 3D model to mimic skin
infection model. This would serve as
an in vitro tool recapitulating enough
biological response for the bio-
evaluation of antimicrobial and wound
healing properties of novel anti
microbial biomaterials.
Testing of medical 
biomaterials
Fig 5: CellTiter-Blue
Fig 3: Immunolabelling
for specific epidermal
marker, Ki67 (arrows)
showed the proliferative
state of basal epidermal
cells, demonstrating the
analogies in the
differentiation program
with in vivo situation.
Scale bar=100 µm
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